your initial deposit *subject to change and depends on individual circumstances.
Immunodiagnostic Systems Holdings plc (IDS) manufactures and distributes medical diagnostic products. The Company is also actively involved in research and development projects. Its range of products includes bone and growth-related products. The principal products of IDS continue to be kits for the determination of vitamin D in human...Read more
Immunodiagnostic Systems in licensing deal with BiosignaturesSeptember 04 2009, 3:08pm
Diagnostic testing kits producer Immunodiagnostic Systems Holdings PLC (AIM: IDH) has agreed licence terms with Biosignatures Ltd to use new biomarkers associated with kidney disease identified through Biosignatures' discovery programme.
Biosignatures, based in Newcastle upon Tyne, is a clinical diagnostic company generating high performance diagnostic signatures of disease states through its proprietary discovery platform.
The agreement plays to the strengths of both companies in accelerating the discovery of new disease biomarkers and feeding these into IS’s immunoassay development machine. The initial focus is to be kidney diseases and related conditions, the group said.
Will Dracup, a non-executive director of IS, is also chief executive of Biosignatures. In the light of the future commercial collaboration, he will reluctantly step down from the IS board with immediate effect.